Real-time enrollment status for this rheumatoid arthritis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT07276581 |
| Recruiting Status | Recruiting |
| Condition | Rheumatoid Arthritis |
| Phase | PHASE2 |
| Target Enrollment | 320 participants |
| Active Locations | 29 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT07276581 is currently recruiting participants. This phase2 study for rheumatoid arthritis is actively seeking new participants at 29 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07276581 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07276581 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.